Rare diseases are not uncommon, and may be the mother lode for the world’s pharmaceutical producers and researchers

//Rare diseases are not uncommon, and may be the mother lode for the world’s pharmaceutical producers and researchers

Rare diseases are not uncommon, and may be the mother lode for the world’s pharmaceutical producers and researchers

Rare diseases may individually affect a relatively small number of patients compared to common ailments but the overall burden on society is heavy and drug developers should not ignore its market potential, says policy advocate.“Rare diseases are not that rare when one considers the fact that each patient’s disease also has a big impact on each of their family members and carers,” said Li Linkang, executive director of China Alliance for Rare Disease. “Medical experts have made a conservative…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2019-07-06T00:00:12+00:00 July 6th, 2019|Business|Comments Off on Rare diseases are not uncommon, and may be the mother lode for the world’s pharmaceutical producers and researchers